- Home
- XERS vs BOW Comparison
XERS vs BOW Comparison
Compare XERS & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- BOW
- Stock Information
- Founded
- XERS 2005
- BOW 2020
- Country
- XERS United States
- BOW United States
- Employees
- XERS N/A
- BOW N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- BOW Property-Casualty Insurers
- Sector
- XERS Health Care
- BOW Finance
- Exchange
- XERS Nasdaq
- BOW Nasdaq
- Market Cap
- XERS 1.3B
- BOW 1.1B
- IPO Year
- XERS 2018
- BOW 2024
- Fundamental
- Price
- XERS $8.33
- BOW $25.80
- Analyst Decision
- XERS Strong Buy
- BOW Buy
- Analyst Count
- XERS 7
- BOW 6
- Target Price
- XERS $8.00
- BOW $36.00
- AVG Volume (30 Days)
- XERS 2.1M
- BOW 357.7K
- Earning Date
- XERS 11-07-2025
- BOW 11-04-2025
- Dividend Yield
- XERS N/A
- BOW N/A
- EPS Growth
- XERS N/A
- BOW 41.97
- EPS
- XERS N/A
- BOW 1.47
- Revenue
- XERS $246,025,000.00
- BOW $492,071,000.00
- Revenue This Year
- XERS $43.89
- BOW $19.49
- Revenue Next Year
- XERS $20.40
- BOW $21.79
- P/E Ratio
- XERS N/A
- BOW $17.57
- Revenue Growth
- XERS 35.62
- BOW 41.21
- 52 Week Low
- XERS $2.73
- BOW $23.70
- 52 Week High
- XERS $8.51
- BOW $42.29
- Technical
- Relative Strength Index (RSI)
- XERS 61.63
- BOW 37.76
- Support Level
- XERS $7.88
- BOW $23.70
- Resistance Level
- XERS $8.51
- BOW $27.22
- Average True Range (ATR)
- XERS 0.37
- BOW 1.00
- MACD
- XERS -0.01
- BOW -0.08
- Stochastic Oscillator
- XERS 83.05
- BOW 41.05
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About BOW Bowhead Specialty Holdings Inc. Common Stock
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.